Skip to main content
Skip to main content
OMI logo

Owens & Minor, Inc. (OMI)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Owens & Minor, Inc. (OMI) trades at $2.68 with AI Score 44/100 (Weak). Owens & Minor is a healthcare solutions company providing medical supplies and services to healthcare providers and manufacturers. Market cap: $207.07M, Sector: Healthcare.

Last analyzed: Feb 8, 2026
Owens & Minor is a healthcare solutions company providing medical supplies and services to healthcare providers and manufacturers. They operate through Global Solutions and Global Products segments, offering a comprehensive portfolio including branded and proprietary products.
44/100 AI Score Target $5.44 (+103.0%) MCap $207.07M Vol 1.97M

Owens & Minor, Inc. (OMI) Healthcare & Pipeline Overview

CEOEdward A. Pesicka
Employees23200
HeadquartersMechanicsville, VA, US
IPO Year1980

Owens & Minor delivers comprehensive healthcare solutions, providing essential medical supplies and services through its Global Solutions and Global Products segments, serving a diverse network of healthcare providers and manufacturers with a commitment to quality and efficiency in the medical distribution landscape.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 8, 2026

Investment Thesis

Investing in Owens & Minor presents a notable opportunity due to its established position in the healthcare distribution market and its comprehensive suite of solutions. While the company currently faces challenges reflected in its negative profit margin of -20.0% and a high Beta of 1.36, strategic initiatives focused on operational efficiency and cost reduction could drive significant improvements. The company's Global Solutions segment, offering high-value services like supplier and inventory management, presents a strong growth catalyst. As healthcare providers increasingly seek to optimize their supply chains, Owens & Minor's expertise in this area becomes increasingly valuable. Furthermore, the Global Products segment, with its focus on infection prevention, aligns with growing healthcare priorities. Successful execution of these strategies, coupled with a potential turnaround in profitability, could lead to significant value creation for investors. Keep in mind the stock data is pending update.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market Cap of $0.21B indicates a relatively small capitalization, potentially offering room for growth.
  • Negative P/E ratio of -0.14 suggests current unprofitability, requiring careful monitoring of turnaround efforts.
  • Gross Margin of 26.1% reflects the company's ability to generate revenue above the cost of goods sold.
  • Beta of 1.36 indicates higher volatility compared to the market, suggesting a riskier investment.
  • No Dividend Yield reflects the company's current focus on reinvesting earnings for growth or addressing financial challenges.

Competitors & Peers

Strengths

  • Comprehensive product and service offerings.
  • Established relationships with healthcare providers.
  • Expertise in supply chain management.
  • Global presence and distribution network.

Weaknesses

  • Negative profit margin.
  • High debt levels.
  • Exposure to economic cycles.
  • Dependence on key suppliers.

Catalysts

  • Implementation of cost reduction initiatives to improve profitability.
  • Expansion of value-added services to drive revenue growth.
  • Potential acquisitions to expand market share and product portfolio.
  • Focus on innovation and development of proprietary products.

Risks

  • Intense competition from larger distributors.
  • Price pressures from healthcare providers and group purchasing organizations.
  • Changes in healthcare regulations and reimbursement policies.
  • Disruptions in the supply chain due to geopolitical events or natural disasters.
  • Integration risks associated with acquisitions.

Growth Opportunities

  • Expansion of Global Solutions Offerings: Owens & Minor can capitalize on the growing demand for supply chain optimization services within the healthcare industry. By expanding its portfolio of analytics, inventory management, and clinical supply management solutions, the company can attract new clients and increase revenue from existing customers. The market for healthcare supply chain management is estimated to reach $20 billion by 2028, presenting a significant growth opportunity.
  • Strategic Acquisitions: Pursuing strategic acquisitions of smaller players in the medical distribution market can enable Owens & Minor to expand its geographic reach, broaden its product portfolio, and gain access to new technologies. This inorganic growth strategy can accelerate market share gains and enhance the company's competitive position. Targets could include companies specializing in niche medical products or innovative supply chain solutions.
  • Penetration of Alternate Site Channels: Owens & Minor can increase its sales by focusing on alternate site channels such as surgery centers, physicians' practices, and home healthcare providers. These channels are experiencing rapid growth due to the shift towards outpatient care and the increasing prevalence of chronic diseases. Tailoring product and service offerings to meet the specific needs of these channels can drive significant revenue growth.
  • Development of Proprietary Products: Investing in the development and commercialization of proprietary medical products can enhance Owens & Minor's profitability and differentiate it from competitors. Focusing on products that address unmet needs in areas such as infection prevention, wound care, and surgical procedures can create a sustainable competitive advantage. These products can command higher margins and generate recurring revenue streams.
  • Leveraging Technology for Efficiency: Implementing advanced technologies such as artificial intelligence, machine learning, and blockchain can improve operational efficiency, reduce costs, and enhance supply chain visibility. Investing in these technologies can enable Owens & Minor to optimize inventory levels, streamline logistics, and improve customer service. The adoption of these technologies can also create new revenue opportunities through data analytics and value-added services.

Opportunities

  • Expansion of value-added services.
  • Strategic acquisitions.
  • Penetration of emerging markets.
  • Development of proprietary products.

Threats

  • Intense competition.
  • Price pressures from healthcare providers.
  • Changes in healthcare regulations.
  • Disruptions in the supply chain.

Competitive Advantages

  • Established relationships with a broad network of healthcare providers.
  • Comprehensive portfolio of products and services.
  • Expertise in supply chain management and logistics.
  • Proprietary products that offer differentiation and higher margins.

About OMI

Founded in 1882 and headquartered in Richmond, Virginia, Owens & Minor, Inc. has evolved into a leading healthcare solutions company operating both in the United States and internationally. The company operates through two primary segments: Global Solutions and Global Products. The Global Solutions segment offers an extensive portfolio of products and services tailored to healthcare providers and manufacturers. This includes a wide array of medical and surgical supplies, encompassing both branded products and Owens & Minor's own proprietary offerings. Beyond product distribution, the Global Solutions segment provides crucial services such as supplier management, advanced analytics, inventory optimization, and clinical supply management. These services aim to streamline operations, reduce costs, and improve patient outcomes for healthcare providers. The Global Products segment focuses on the manufacturing and sourcing of medical-surgical products designed to prevent healthcare-associated infections. This segment's product portfolio includes essential items like sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, and custom procedure kits. Owens & Minor serves a diverse customer base, including multi-facility healthcare networks, independent hospitals, surgery centers, physicians' practices, and networks of hospitals, both directly and through third-party distributors. With a history spanning over a century, Owens & Minor has established itself as a trusted partner in the healthcare industry, committed to delivering quality products and innovative solutions that support the delivery of exceptional patient care.

What They Do

  • Distributes medical and surgical supplies to healthcare providers.
  • Offers supplier management services to hospitals and healthcare networks.
  • Provides inventory management solutions to optimize supply chains.
  • Manufactures and sources medical-surgical products for infection prevention.
  • Offers clinical supply management services to improve patient care.
  • Provides analytics to help healthcare providers make informed decisions.
  • Offers sterilization wraps, surgical drapes and gowns, and other medical products.

Business Model

  • Generates revenue through the sale of medical and surgical supplies.
  • Earns fees for providing supply chain management and consulting services.
  • Profits from the manufacturing and distribution of proprietary medical products.

Industry Context

Owens & Minor operates within the medical distribution industry, a sector characterized by increasing demand for efficient supply chain solutions and cost containment. The industry is driven by factors such as an aging population, rising healthcare expenditures, and technological advancements in medical treatments. Competition is intense, with companies like ACRS (Accretive Health) and ALLO (Allogene Therapeutics) vying for market share. Owens & Minor's focus on both product manufacturing and service solutions positions it to capitalize on the growing trend of integrated healthcare delivery models. The medical distribution market is expected to continue growing, driven by the need for streamlined supply chains and cost-effective healthcare solutions.

Key Customers

  • Multi-facility networks of healthcare providers.
  • Independent hospitals and surgery centers.
  • Physicians' practices and clinics.
  • Networks of hospitals and integrated delivery systems.
AI Confidence: 71% Updated: Feb 8, 2026

Financials

Chart & Info

Owens & Minor, Inc. (OMI) stock price: $2.68 (+0.22, +8.94%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for OMI.

Price Targets

Consensus target: $5.44

MoonshotScore

44/100

What does this score mean?

The MoonshotScore rates OMI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Owens & Minor, Inc. Healthcare Stock: Key Questions Answered

What does Owens & Minor, Inc. do?

Owens & Minor, Inc. operates as a healthcare solutions company, providing a comprehensive range of medical supplies, equipment, and services to healthcare providers and manufacturers. Through its Global Solutions segment, the company offers supplier management, analytics, and inventory management services. The Global Products segment manufactures and sources medical-surgical products, including sterilization wraps, surgical drapes, and protective apparel. OMI serves a diverse customer base, including hospitals, surgery centers, and physician practices, playing a crucial role in the healthcare supply chain.

Is OMI stock worth researching?

Evaluating OMI stock requires careful consideration of its current financial performance and future growth potential. The company's negative profit margin and high beta raise concerns, but its established market position and comprehensive service offerings provide a foundation for future growth. Successful execution of strategic initiatives, such as cost reduction and expansion of value-added services, could improve profitability and drive shareholder value. Investors should closely monitor the company's progress in these areas and assess the overall risk-reward profile before making an investment decision. Keep in mind the stock data is pending update.

What are the main risks for OMI?

Owens & Minor faces several key risks, including intense competition from larger distributors, price pressures from healthcare providers, and potential disruptions in the supply chain. Changes in healthcare regulations and reimbursement policies could also negatively impact the company's financial performance. Additionally, integration risks associated with acquisitions and dependence on key suppliers pose challenges. Effective management of these risks is crucial for Owens & Minor to maintain its competitive position and achieve sustainable growth.

What are the key factors to evaluate for OMI?

Owens & Minor, Inc. (OMI) currently holds an AI score of 44/100, indicating low score. Analysts target $5.44 (+103% from $2.68). Key strength: Comprehensive product and service offerings. Primary risk to monitor: Intense competition from larger distributors. This is not financial advice.

How frequently does OMI data refresh on this page?

OMI prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven OMI's recent stock price performance?

Recent price movement in Owens & Minor, Inc. (OMI) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $5.44 implies 103% upside from here. Notable catalyst: Comprehensive product and service offerings. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider OMI overvalued or undervalued right now?

Determining whether Owens & Minor, Inc. (OMI) is overvalued or undervalued requires examining multiple metrics. Analysts target $5.44 (+103% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying OMI?

Before investing in Owens & Minor, Inc. (OMI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Financial data is based on the most recent available information.
  • Future performance is subject to market conditions and company-specific factors.
Data Sources

Popular Stocks